Online Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts

Written By :  sheeba farhat
Published On 2026-01-09 17:58 GMT   |   Update On 2026-01-09 17:58 GMT
Advertisement

Bengaluru: Online ⁠pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic, sourced from India to U.S. patients, as demand for cheaper options grows.

The Canada-based ‌company said ‌the India-sourced Ozempic injections are priced from about $280 per pen, compared with U.S. retail pharmacy prices ‌that typically range between $900 and $1,100 per pen depending on dose and location.

Advertisement

It was not clear how the online pharmacy was obtaining the weight-loss treatment. The company did not respond to an emailed request for comment about its sourcing. ​When contacted by phone on Thursday using the ​toll-free number listed on SaveRxCanada.to, a person said the company ‌had no ‍comment.

"We have no customer or partner relationship with this company/platform, ‍and Ozempic from India has not been provided to ‌them," a Novo Nordisk spokesperson told Reuters in an email on Thursday when asked about SaveRxCanada.to.

A spokesperson for the U.S. Department of Health and Human Services declined to comment on the company's distribution claims, pointing consumers to the FDA's BeSafeRx resource on how to safely buy prescription medicines online.

The platform is offering several pre-filled ‍pens including 0.25 mg, 0.5 mg and 1 mg doses, and said products clearly disclose the manufacturer and country ‍of origin. All orders ⁠require a valid ⁠prescription and include free shipping, it added.

"Many patients are actively comparing prescription costs as U.S. prices continue to rise," the company said in a statement.

The platform, which describes itself as an international prescription referral service, said it has operated for 24 years connecting patients with licensed pharmacies outside the United States.International pharmacy services have drawn interest from U.S. consumers facing rising out-of-pocket drug expenses.

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News